Catalyst Wire Dossier Catalyst Wire Dossier

Taurolock Hep100

taurolidine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Taurolock Hep100, covering 2024-10-28 to 2024-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial Comparing TaurolockTMHep100 (Taurolidine 1.35%) and 0.9% Saline As Prevention of Recurrent Catheter-related Bloodstream Infections [NA]

See pricing